Stay updated with the latest emicizumab news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on emicizumab topics.
New Delhi: The GST rate cuts announced last week will make medicines used for the treatment of critical conditions like multiple myeloma, lung cancer, blood cancer, lymphoma, Gaucher disease, Pompe disease and haemophilia significantly cheaper and help more patients to avail of treatment, health experts said. A pack of leukaemia drug asciminib 60 (40 mg tablets), which used to cost ₹2,35,000 with GST, will become cheaper by ₹25,000, as per data from market research firm PharmaTrac. Obinutuzu ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.